United States Biotechnology & Medical Research

Madrigal Pharmaceuticals Inc (MDGL)

Track

Track

Madrigal Pharmaceuticals experienced thirteen insider trading transactions over the past ninety days, totaling approximately 3.43 million dollars in sales. Key executives, including the CEO and General Counsel, offloaded shares following a positive earnings report. These divestments occurred while the stock price maintained a sixteen percent gain during this period.
Ticker: MDGL Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Madrigal Pharmaceuticals Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
1.6
Kelley Shannon T General Counsel Officer
Transaction date
Sale
Price
398.26
Quantity 53,686 -10.9%
Value US$1,141,302
1.6
Shannon Kelley Officer Officer
Transaction date
Proposed sale
Price
261.40
Quantity 41,039
Value US$856,250
2.6
Sibold William John President and CEO Executive Director
Transaction date
Sale
Price
193.23
Quantity 13,578 -10.5%
Value US$4,281,081
2.6
Sibold William John President and CEO Executive Director
Transaction date
Sale
Price
550.72
Quantity 1 -0.0%
Value US$551
2.6
Sibold William John President and CEO Executive Director
Transaction date
Sale
Price
550.01
Quantity 153 -0.1%
Value US$84,152
2.6
Sibold William John President and CEO Executive Director
Transaction date
Sale
Price
548.87
Quantity 47 -0.0%
Value US$25,797
2.6
Sibold William John President and CEO Executive Director
Transaction date
Sale
Price
547.70
Quantity 680 -0.3%
Value US$372,435
2.6
Sibold William John President and CEO Executive Director
Transaction date
Sale
Price
547.08
Quantity 269 -0.1%
Value US$147,164
2.6
Sibold William John President and CEO Executive Director
Transaction date
Sale
Price
545.71
Quantity 275 -0.1%
Value US$150,070
2.6
Sibold William John President and CEO Executive Director
Transaction date
Sale
Price
544.71
Quantity 545 -0.3%
Value US$296,869
2.6
Sibold William John President and CEO Executive Director
Transaction date
Sale
Price
543.79
Quantity 110 -0.1%
Value US$59,817
2.6
Sibold William John President and CEO Executive Director
Transaction date
Sale
Price
542.75
Quantity 140 -0.1%
Value US$75,984
2.6
William Sibold Officer and Director Executive Director
Transaction date
Proposed sale
Price
553.48
Quantity 2,500
Value US$1,383,700
Soergel David Chief Medical Officer Officer
Transaction date
Planned sale
Price
495.74
Quantity 1,042 -9.4%
Value US$516,561
DAVID SOERGEL Officer Officer
Transaction date
Proposed sale
Price
497.27
Quantity 1,042
Value US$518,155
3.5
Levy Richard S Non-Executive Director
Transaction date
Planned sale
Price
519.98
Quantity 80 -0.4%
Value US$41,598
3.5
Levy Richard S Non-Executive Director
Transaction date
Planned sale
Price
518.76
Quantity 782 -3.4%
Value US$405,669
3.5
Levy Richard S Non-Executive Director
Transaction date
Planned sale
Price
517.59
Quantity 1,497 -6.1%
Value US$774,835
3.5
Levy Richard S Non-Executive Director
Transaction date
Planned sale
Price
516.87
Quantity 723 -2.9%
Value US$373,694
3.5
Levy Richard S Non-Executive Director
Transaction date
Planned sale
Price
515.92
Quantity 657 -2.6%
Value US$338,961
3.5
Levy Richard S Non-Executive Director
Transaction date
Planned sale
Price
514.67
Quantity 343 -1.3%
Value US$176,532
3.5
Levy Richard S Non-Executive Director
Transaction date
Planned sale
Price
512.97
Quantity 40 -0.2%
Value US$20,519
3.5
Levy Richard S Non-Executive Director
Transaction date
Planned sale
Price
512.50
Quantity 439 -1.7%
Value US$224,988
3.5
Levy Richard S Non-Executive Director
Transaction date
Planned sale
Price
511.40
Quantity 610 -2.2%
Value US$311,952
3.5
Levy Richard S Non-Executive Director
Transaction date
Planned sale
Price
510.36
Quantity 151 -0.6%
Value US$77,064
3.5
Levy Richard S Non-Executive Director
Transaction date
Planned sale
Price
508.24
Quantity 320 -1.2%
Value US$162,637
3.5
Levy Richard S Non-Executive Director
Transaction date
Planned sale
Price
506.68
Quantity 40 -0.1%
Value US$20,267
3.5
RICHARD LEVY Director Non-Executive Director
Transaction date
Proposed sale
Price
513.59
Quantity 5,682
Value US$2,918,218
David Soergel Officer Officer
Transaction date
Proposed sale
Price
523.69
Quantity 844
Value US$441,994
Soergel David Chief Medical Officer Officer
Transaction date
Sale
Price
515.90
Quantity 844 -7.1%
Value US$435,420
2.4
Dier Mardi EVP and CFO Officer
Transaction date
Planned sale
Price
437.65
Quantity 40 -0.3%
Value US$17,506
2.4
Dier Mardi EVP and CFO Officer
Transaction date
Planned sale
Price
436.69
Quantity 80 -0.6%
Value US$34,935
2.4
Dier Mardi EVP and CFO Officer
Transaction date
Planned sale
Price
435.32
Quantity 80 -0.6%
Value US$34,825
2.4
Dier Mardi EVP and CFO Officer
Transaction date
Planned sale
Price
434.20
Quantity 160 -1.2%
Value US$69,472
2.4
Dier Mardi EVP and CFO Officer
Transaction date
Planned sale
Price
432.56
Quantity 116 -0.9%
Value US$50,176
2.4
Dier Mardi EVP and CFO Officer
Transaction date
Planned sale
Price
430.90
Quantity 120 -0.9%
Value US$51,708
2.4
Dier Mardi EVP and CFO Officer
Transaction date
Planned sale
Price
429.58
Quantity 40 -0.3%
Value US$17,183
2.4
Dier Mardi EVP and CFO Officer
Transaction date
Planned sale
Price
429.00
Quantity 160 -1.2%
Value US$68,639
2.4
Dier Mardi EVP and CFO Officer
Transaction date
Planned sale
Price
427.85
Quantity 80 -0.6%
Value US$34,228
2.4
Dier Mardi EVP and CFO Officer
Transaction date
Planned sale
Price
426.86
Quantity 420 -3.0%
Value US$179,283
2.4
Dier Mardi EVP and CFO Officer
Transaction date
Planned sale
Price
425.08
Quantity 40 -0.3%
Value US$17,003
2.4
Dier Mardi EVP and CFO Officer
Transaction date
Sale
Price
431.94
Quantity 646 -4.5%
Value US$279,033
2.4
Mardi Dier Officer Officer
Transaction date
Proposed sale
Price
439.34
Quantity 646
Value US$283,814
2.6
Sibold William John President and CEO Executive Director
Transaction date
Sale
Price
431.94
Quantity 1,663 -1.0%
Value US$718,316
2.6
William Sibold Officer and Director Executive Director
Transaction date
Proposed sale
Price
439.34
Quantity 1,663
Value US$730,622
1.6
Kelley Shannon T General Counsel Officer
Transaction date
Sale
Price
431.94
Quantity 360 -2.9%
Value US$155,498
1.6
Shannon Kelley Officer Officer
Transaction date
Proposed sale
Price
439.34
Quantity 360
Value US$158,162
2.8
Huntsman Carole Chief Commercial Officer Officer
Transaction date
Sale
Price
431.94
Quantity 419 -3.2%
Value US$180,983
2.8
Carole Huntsman Officer Officer
Transaction date
Proposed sale
Price
439.34
Quantity 419
Value US$184,083
2.4
Taub Rebecca Non-Executive Director
Transaction date
Sale
Price
431.94
Quantity 491 -0.1%
Value US$212,083
2.4
Rebecca Taub Director Non-Executive Director
Transaction date
Proposed sale
Price
439.34
Quantity 491
Value US$215,716
2.4
MARDI DIER Officer Officer
Transaction date
Proposed sale
Price
439.34
Quantity 1,336
Value US$586,958
2.4
Dier Mardi EVP and CFO Officer
Transaction date
Sale
Price
427.21
Quantity 1,183 -11.3%
Value US$505,389
2.4
Mardi Dier Officer Officer
Transaction date
Proposed sale
Price
432.00
Quantity 1,183
Value US$511,056
2.8
CAROLE A HUNTSMAN Officer Officer
Transaction date
Proposed sale
Price
480.45
Quantity 570
Value US$273,856
2.8
Carole Huntsman Officer Officer
Transaction date
Proposed sale
Price
480.45
Quantity 340
Value US$163,353
2.6
William Sibold Officer and Director Executive Director
Transaction date
Proposed sale
Price
480.45
Quantity 1,577
Value US$757,670
2.4
Rebecca Taub Director Non-Executive Director
Transaction date
Proposed sale
Price
480.45
Quantity 647
Value US$310,851
2.8
Huntsman Carole Chief Commercial Officer Officer
Transaction date
Planned sale
Price
494.59
Quantity 570 -5.9%
Value US$281,916
2.8
Huntsman Carole Chief Commercial Officer Officer
Transaction date
Sale
Price
492.42
Quantity 340 -3.4%
Value US$167,423
2.6
Sibold William John President and CEO Executive Director
Transaction date
Sale
Price
492.42
Quantity 1,577 -1.1%
Value US$776,546
2.4
Taub Rebecca Non-Executive Director
Transaction date
Sale
Price
492.42
Quantity 647 -0.1%
Value US$318,596
1.6
SHANNON KELLEY Officer Officer
Transaction date
Proposed sale
Price
501.68
Quantity 429
Value US$215,221
1.6
Shannon Kelley Officer Officer
Transaction date
Proposed sale
Price
501.68
Quantity 263
Value US$131,942
2.4
Rebecca Taub Director Non-Executive Director
Transaction date
Proposed sale
Price
501.68
Quantity 2,238
Value US$1,122,760
1.6
Kelley Shannon T General Counsel Officer
Transaction date
Planned sale
Price
501.40
Quantity 429 -4.8%
Value US$215,101
1.6
Kelley Shannon T General Counsel Officer
Transaction date
Sale
Price
490.77
Quantity 263 -2.9%
Value US$129,073
2.4
Taub Rebecca Non-Executive Director
Transaction date
Sale
Price
490.77
Quantity 2,238 -0.5%
Value US$1,098,343
2.5
FRIEDMAN PAUL A Non-Executive Director
Transaction date
Planned sale
Price
545.79
Quantity 40 -0.0%
Value US$21,832
2.5
FRIEDMAN PAUL A Non-Executive Director
Transaction date
Planned sale
Price
540.36
Quantity 600 -0.3%
Value US$324,215
2.5
FRIEDMAN PAUL A Non-Executive Director
Transaction date
Planned sale
Price
539.23
Quantity 480 -0.3%
Value US$258,831
2.5
FRIEDMAN PAUL A Non-Executive Director
Transaction date
Planned sale
Price
537.85
Quantity 80 -0.0%
Value US$43,028
2.5
FRIEDMAN PAUL A Non-Executive Director
Transaction date
Planned sale
Price
536.88
Quantity 487 -0.3%
Value US$261,459
2.5
FRIEDMAN PAUL A Non-Executive Director
Transaction date
Planned sale
Price
536.02
Quantity 473 -0.2%
Value US$253,538
2.5
FRIEDMAN PAUL A Non-Executive Director
Transaction date
Planned sale
Price
535.29
Quantity 148 -0.1%
Value US$79,223
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-20 2026-08-17 S Sale
1.6
Kelley Shannon T

General Counsel

Officer
53,686 -10.9%
398.26
US$1,141,302 		53,686 -10.9% 398.26 US$1,141,302
2026-08-20 2026-08-17 PrS Proposed sale
1.6
Shannon Kelley

Officer

Officer
41,039
261.40
US$856,250 		41,039 261.40 US$856,250
2026-07-20 2026-07-20 S Sale
2.6
Sibold William John

President and CEO

Executive Director
13,578 -10.5%
193.23
US$4,281,081 		13,578 -10.5% 193.23 US$4,281,081
2026-07-20 2026-07-20 S Sale
2.6
Sibold William John

President and CEO

Executive Director
1 -0.0%
550.72
US$551 		1 -0.0% 550.72 US$551
2026-07-20 2026-07-20 S Sale
2.6
Sibold William John

President and CEO

Executive Director
153 -0.1%
550.01
US$84,152 		153 -0.1% 550.01 US$84,152
2026-07-20 2026-07-20 S Sale
2.6
Sibold William John

President and CEO

Executive Director
47 -0.0%
548.87
US$25,797 		47 -0.0% 548.87 US$25,797
2026-07-20 2026-07-20 S Sale
2.6
Sibold William John

President and CEO

Executive Director
680 -0.3%
547.70
US$372,435 		680 -0.3% 547.70 US$372,435
2026-07-20 2026-07-20 S Sale
2.6
Sibold William John

President and CEO

Executive Director
269 -0.1%
547.08
US$147,164 		269 -0.1% 547.08 US$147,164
2026-07-20 2026-07-20 S Sale
2.6
Sibold William John

President and CEO

Executive Director
275 -0.1%
545.71
US$150,070 		275 -0.1% 545.71 US$150,070
2026-07-20 2026-07-20 S Sale
2.6
Sibold William John

President and CEO

Executive Director
545 -0.3%
544.71
US$296,869 		545 -0.3% 544.71 US$296,869
2026-07-20 2026-07-20 S Sale
2.6
Sibold William John

President and CEO

Executive Director
110 -0.1%
543.79
US$59,817 		110 -0.1% 543.79 US$59,817
2026-07-20 2026-07-20 S Sale
2.6
Sibold William John

President and CEO

Executive Director
140 -0.1%
542.75
US$75,984 		140 -0.1% 542.75 US$75,984
2026-07-20 2026-07-20 PrS Proposed sale
2.6
William Sibold

Officer and Director

Executive Director
2,500
553.48
US$1,383,700 		2,500 553.48 US$1,383,700
2026-06-01 2026-06-01 PlS Planned sale
Soergel David

Chief Medical Officer

Officer
1,042 -9.4%
495.74
US$516,561 		1,042 -9.4% 495.74 US$516,561
2026-06-01 2026-06-01 PrS Proposed sale
DAVID SOERGEL

Officer

Officer
1,042
497.27
US$518,155 		1,042 497.27 US$518,155
2026-05-22 2026-05-22 PlS Planned sale
3.5
Levy Richard S
Non-Executive Director
80 -0.4%
519.98
US$41,598 		80 -0.4% 519.98 US$41,598
2026-05-22 2026-05-22 PlS Planned sale
3.5
Levy Richard S
Non-Executive Director
782 -3.4%
518.76
US$405,669 		782 -3.4% 518.76 US$405,669
2026-05-22 2026-05-22 PlS Planned sale
3.5
Levy Richard S
Non-Executive Director
1,497 -6.1%
517.59
US$774,835 		1,497 -6.1% 517.59 US$774,835
2026-05-22 2026-05-22 PlS Planned sale
3.5
Levy Richard S
Non-Executive Director
723 -2.9%
516.87
US$373,694 		723 -2.9% 516.87 US$373,694
2026-05-22 2026-05-22 PlS Planned sale
3.5
Levy Richard S
Non-Executive Director
657 -2.6%
515.92
US$338,961 		657 -2.6% 515.92 US$338,961
2026-05-22 2026-05-22 PlS Planned sale
3.5
Levy Richard S
Non-Executive Director
343 -1.3%
514.67
US$176,532 		343 -1.3% 514.67 US$176,532
2026-05-22 2026-05-22 PlS Planned sale
3.5
Levy Richard S
Non-Executive Director
40 -0.2%
512.97
US$20,519 		40 -0.2% 512.97 US$20,519
2026-05-22 2026-05-22 PlS Planned sale
3.5
Levy Richard S
Non-Executive Director
439 -1.7%
512.50
US$224,988 		439 -1.7% 512.50 US$224,988
2026-05-22 2026-05-22 PlS Planned sale
3.5
Levy Richard S
Non-Executive Director
610 -2.2%
511.40
US$311,952 		610 -2.2% 511.40 US$311,952
2026-05-22 2026-05-22 PlS Planned sale
3.5
Levy Richard S
Non-Executive Director
151 -0.6%
510.36
US$77,064 		151 -0.6% 510.36 US$77,064
2026-05-22 2026-05-22 PlS Planned sale
3.5
Levy Richard S
Non-Executive Director
320 -1.2%
508.24
US$162,637 		320 -1.2% 508.24 US$162,637
2026-05-22 2026-05-22 PlS Planned sale
3.5
Levy Richard S
Non-Executive Director
40 -0.1%
506.68
US$20,267 		40 -0.1% 506.68 US$20,267
2026-05-22 2026-05-22 PrS Proposed sale
3.5
RICHARD LEVY

Director

Non-Executive Director
5,682
513.59
US$2,918,218 		5,682 513.59 US$2,918,218
2026-05-18 2026-05-18 PrS Proposed sale
David Soergel

Officer

Officer
844
523.69
US$441,994 		844 523.69 US$441,994
2026-05-18 2026-05-18 S Sale
Soergel David

Chief Medical Officer

Officer
844 -7.1%
515.90
US$435,420 		844 -7.1% 515.90 US$435,420
2026-03-06 2026-03-06 PlS Planned sale
2.4
Dier Mardi

EVP and CFO

Officer
40 -0.3%
437.65
US$17,506 		40 -0.3% 437.65 US$17,506
2026-03-06 2026-03-06 PlS Planned sale
2.4
Dier Mardi

EVP and CFO

Officer
80 -0.6%
436.69
US$34,935 		80 -0.6% 436.69 US$34,935
2026-03-06 2026-03-06 PlS Planned sale
2.4
Dier Mardi

EVP and CFO

Officer
80 -0.6%
435.32
US$34,825 		80 -0.6% 435.32 US$34,825
2026-03-06 2026-03-06 PlS Planned sale
2.4
Dier Mardi

EVP and CFO

Officer
160 -1.2%
434.20
US$69,472 		160 -1.2% 434.20 US$69,472
2026-03-06 2026-03-06 PlS Planned sale
2.4
Dier Mardi

EVP and CFO

Officer
116 -0.9%
432.56
US$50,176 		116 -0.9% 432.56 US$50,176
2026-03-06 2026-03-06 PlS Planned sale
2.4
Dier Mardi

EVP and CFO

Officer
120 -0.9%
430.90
US$51,708 		120 -0.9% 430.90 US$51,708
2026-03-06 2026-03-06 PlS Planned sale
2.4
Dier Mardi

EVP and CFO

Officer
40 -0.3%
429.58
US$17,183 		40 -0.3% 429.58 US$17,183
2026-03-06 2026-03-06 PlS Planned sale
2.4
Dier Mardi

EVP and CFO

Officer
160 -1.2%
429.00
US$68,639 		160 -1.2% 429.00 US$68,639
2026-03-06 2026-03-06 PlS Planned sale
2.4
Dier Mardi

EVP and CFO

Officer
80 -0.6%
427.85
US$34,228 		80 -0.6% 427.85 US$34,228
2026-03-06 2026-03-06 PlS Planned sale
2.4
Dier Mardi

EVP and CFO

Officer
420 -3.0%
426.86
US$179,283 		420 -3.0% 426.86 US$179,283
2026-03-06 2026-03-06 PlS Planned sale
2.4
Dier Mardi

EVP and CFO

Officer
40 -0.3%
425.08
US$17,003 		40 -0.3% 425.08 US$17,003
2026-03-06 2026-03-06 S Sale
2.4
Dier Mardi

EVP and CFO

Officer
646 -4.5%
431.94
US$279,033 		646 -4.5% 431.94 US$279,033
2026-03-06 2026-03-06 PrS Proposed sale
2.4
Mardi Dier

Officer

Officer
646
439.34
US$283,814 		646 439.34 US$283,814
2026-03-06 2026-03-06 S Sale
2.6
Sibold William John

President and CEO

Executive Director
1,663 -1.0%
431.94
US$718,316 		1,663 -1.0% 431.94 US$718,316
2026-03-06 2026-03-06 PrS Proposed sale
2.6
William Sibold

Officer and Director

Executive Director
1,663
439.34
US$730,622 		1,663 439.34 US$730,622
2026-03-06 2026-03-06 S Sale
1.6
Kelley Shannon T

General Counsel

Officer
360 -2.9%
431.94
US$155,498 		360 -2.9% 431.94 US$155,498
2026-03-06 2026-03-06 PrS Proposed sale
1.6
Shannon Kelley

Officer

Officer
360
439.34
US$158,162 		360 439.34 US$158,162
2026-03-06 2026-03-06 S Sale
2.8
Huntsman Carole

Chief Commercial Officer

Officer
419 -3.2%
431.94
US$180,983 		419 -3.2% 431.94 US$180,983
2026-03-06 2026-03-06 PrS Proposed sale
2.8
Carole Huntsman

Officer

Officer
419
439.34
US$184,083 		419 439.34 US$184,083
2026-03-06 2026-03-06 S Sale
2.4
Taub Rebecca
Non-Executive Director
491 -0.1%
431.94
US$212,083 		491 -0.1% 431.94 US$212,083
2026-03-06 2026-03-06 PrS Proposed sale
2.4
Rebecca Taub

Director

Non-Executive Director
491
439.34
US$215,716 		491 439.34 US$215,716
2026-03-06 2026-03-06 PrS Proposed sale
2.4
MARDI DIER

Officer

Officer
1,336
439.34
US$586,958 		1,336 439.34 US$586,958
2026-03-02 2026-03-02 S Sale
2.4
Dier Mardi

EVP and CFO

Officer
1,183 -11.3%
427.21
US$505,389 		1,183 -11.3% 427.21 US$505,389
2026-03-02 2026-03-02 PrS Proposed sale
2.4
Mardi Dier

Officer

Officer
1,183
432.00
US$511,056 		1,183 432.00 US$511,056
2026-01-26 2026-01-26 PrS Proposed sale
2.8
CAROLE A HUNTSMAN

Officer

Officer
570
480.45
US$273,856 		570 480.45 US$273,856
2026-01-26 2026-01-26 PrS Proposed sale
2.8
Carole Huntsman

Officer

Officer
340
480.45
US$163,353 		340 480.45 US$163,353
2026-01-26 2026-01-26 PrS Proposed sale
2.6
William Sibold

Officer and Director

Executive Director
1,577
480.45
US$757,670 		1,577 480.45 US$757,670
2026-01-26 2026-01-26 PrS Proposed sale
2.4
Rebecca Taub

Director

Non-Executive Director
647
480.45
US$310,851 		647 480.45 US$310,851
2026-01-26 2026-01-26 PlS Planned sale
2.8
Huntsman Carole

Chief Commercial Officer

Officer
570 -5.9%
494.59
US$281,916 		570 -5.9% 494.59 US$281,916
2026-01-26 2026-01-26 S Sale
2.8
Huntsman Carole

Chief Commercial Officer

Officer
340 -3.4%
492.42
US$167,423 		340 -3.4% 492.42 US$167,423
2026-01-26 2026-01-26 S Sale
2.6
Sibold William John

President and CEO

Executive Director
1,577 -1.1%
492.42
US$776,546 		1,577 -1.1% 492.42 US$776,546
2026-01-26 2026-01-26 S Sale
2.4
Taub Rebecca
Non-Executive Director
647 -0.1%
492.42
US$318,596 		647 -0.1% 492.42 US$318,596
2026-01-20 2026-01-20 PrS Proposed sale
1.6
SHANNON KELLEY

Officer

Officer
429
501.68
US$215,221 		429 501.68 US$215,221
2026-01-20 2026-01-20 PrS Proposed sale
1.6
Shannon Kelley

Officer

Officer
263
501.68
US$131,942 		263 501.68 US$131,942
2026-01-20 2026-01-20 PrS Proposed sale
2.4
Rebecca Taub

Director

Non-Executive Director
2,238
501.68
US$1,122,760 		2,238 501.68 US$1,122,760
2026-01-20 2026-01-20 PlS Planned sale
1.6
Kelley Shannon T

General Counsel

Officer
429 -4.8%
501.40
US$215,101 		429 -4.8% 501.40 US$215,101
2026-01-20 2026-01-20 S Sale
1.6
Kelley Shannon T

General Counsel

Officer
263 -2.9%
490.77
US$129,073 		263 -2.9% 490.77 US$129,073
2026-01-20 2026-01-20 S Sale
2.4
Taub Rebecca
Non-Executive Director
2,238 -0.5%
490.77
US$1,098,343 		2,238 -0.5% 490.77 US$1,098,343
2026-01-13 2026-01-09 PlS Planned sale
2.5
FRIEDMAN PAUL A
Non-Executive Director
40 -0.0%
545.79
US$21,832 		40 -0.0% 545.79 US$21,832
2026-01-13 2026-01-09 PlS Planned sale
2.5
FRIEDMAN PAUL A
Non-Executive Director
600 -0.3%
540.36
US$324,215 		600 -0.3% 540.36 US$324,215
2026-01-13 2026-01-09 PlS Planned sale
2.5
FRIEDMAN PAUL A
Non-Executive Director
480 -0.3%
539.23
US$258,831 		480 -0.3% 539.23 US$258,831
2026-01-13 2026-01-09 PlS Planned sale
2.5
FRIEDMAN PAUL A
Non-Executive Director
80 -0.0%
537.85
US$43,028 		80 -0.0% 537.85 US$43,028
2026-01-13 2026-01-09 PlS Planned sale
2.5
FRIEDMAN PAUL A
Non-Executive Director
487 -0.3%
536.88
US$261,459 		487 -0.3% 536.88 US$261,459
2026-01-13 2026-01-09 PlS Planned sale
2.5
FRIEDMAN PAUL A
Non-Executive Director
473 -0.2%
536.02
US$253,538 		473 -0.2% 536.02 US$253,538
2026-01-13 2026-01-09 PlS Planned sale
2.5
FRIEDMAN PAUL A
Non-Executive Director
148 -0.1%
535.29
US$79,223 		148 -0.1% 535.29 US$79,223
Explore more

More insider trading research around Madrigal Pharmaceuticals Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America